» Articles » PMID: 31266540

6-Gingerol Stabilized the P-VEGFR2/VE-cadherin/β-catenin/actin Complex Promotes Microvessel Normalization and Suppresses Tumor Progression

Overview
Publisher Biomed Central
Specialty Oncology
Date 2019 Jul 4
PMID 31266540
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anti-angiogenic therapies demonstrate anti-tumor effects by decreasing blood supply to tumors and inhibiting tumor growth. However, anti-angiogenic therapy may leads to changes in tumor microenvironment and increased invasiveness of tumor cells, which in turn promotes distant metastasis and increased drug resistance.

Methods: The CO-IP assays, N-STORM and cytoskeleton analysis were used to confirm the mechanism that p-VEGFR2/VE-cadherin/β-catenin/actin complex regulates vascular remodeling and improves the tumor microenvironment. 6-gingerol (6G), the major bioactive component in ginger, stabilized this complex by enhancing the binding of VEGFa to VEGFR2 with non-pathway dependent. Biacore, pull down and molecular docking were employed to confirm the interaction between 6G and VEGFR2 and enhancement of VEGFa binding to VEGFR2.

Results: Here, we report that microvascular structural entropy (MSE) may be a prognostic factor in several tumor types and have potential as a biomarker in the clinic. 6G regulates the structural organization of the microvascular bed to decrease MSE via the p-VEGFR2/VE-cadherin/β-catenin/actin complex and inhibit tumor progression. 6G promotes the normalization of tumor vessels, improves the tumor microenvironment and decreases MSE, facilitating the delivery of chemotherapeutic agents into the tumor core and thereby reducing tumor growth and metastasis.

Conclusions: This study demonstrated the importance of vascular normalization in tumor therapy and elucidated the mechanism of action of ginger, a medicinal compound that has been used in China since ancient times.

Citing Articles

Oncogene OSTM1 Promotes Gastric-Cancer Metastasis by Modulating the Metastatic Microenvironment Through Altered Tumor-Cell Autocrine Signaling.

Tang Y, Guo Y, Feng J, Wang Z Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852172 PMC: 11840279. DOI: 10.3390/cimb47010055.


Screening and identification of vascular endothelial cell targeting peptide in gastric cancer through novel integrated in vitro and in vivo strategy.

Zhang Y, Wang S, Zhao L, Wang H, Wang L, Shi R BMC Cancer. 2024; 24(1):1595.

PMID: 39736630 PMC: 11687070. DOI: 10.1186/s12885-024-13375-3.


Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.

Qi J, Li J, Zhu X, Zhao S PLoS One. 2024; 19(7):e0304597.

PMID: 38954708 PMC: 11218952. DOI: 10.1371/journal.pone.0304597.


Melatonin-induced upregulation of telomerase activity interferes with macrophage mitochondrial metabolism and suppresses NLRP3 inflammasome activation in the treatment of Pneumonia.

Jiang W, Liu J, Zhao X, Yang W Heliyon. 2024; 10(8):e29681.

PMID: 38665558 PMC: 11044047. DOI: 10.1016/j.heliyon.2024.e29681.


Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy.

Huo H, Feng Y, Tang Q Cancer Chemother Pharmacol. 2024; 93(5):397-410.

PMID: 38172304 PMC: 11043148. DOI: 10.1007/s00280-023-04630-8.


References
1.
Kayser K, Gabius H . The application of thermodynamic principles to histochemical and morphometric tissue research: principles and practical outline with focus on the glycosciences. Cell Tissue Res. 1999; 296(3):443-55. DOI: 10.1007/s004410051305. View

2.
Jain R . Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med. 2001; 7(9):987-9. DOI: 10.1038/nm0901-987. View

3.
Vidal S, Horvath E, Kovacs K, Lloyd R, Scheithauer B . Microvascular structural entropy: a novel approach to assess angiogenesis in pituitary tumors. Endocr Pathol. 2003; 14(3):239-47. DOI: 10.1007/s12022-003-0016-0. View

4.
Tong R, Boucher Y, Kozin S, Winkler F, Hicklin D, Jain R . Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 2004; 64(11):3731-6. DOI: 10.1158/0008-5472.CAN-04-0074. View

5.
Jain R . Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005; 307(5706):58-62. DOI: 10.1126/science.1104819. View